These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5963772)

  • 1. Effects of 3,4-dimethoxyphenylethylamine in man.
    Hollister LE; Friedhoff AJ
    Nature; 1966 Jun; 210(5043):1377-8. PubMed ID: 5963772
    [No Abstract]   [Full Text] [Related]  

  • 2. Structure-activity relationship studies on mescaline. II. Tolerance and cross-tolerance between mescaline and its analogues in the rat.
    Smythies JR; Sykes EA; Lord CP
    Psychopharmacologia; 1966; 9(5):434-46. PubMed ID: 5998418
    [No Abstract]   [Full Text] [Related]  

  • 3. Facilitation and disruption by mescaline and 3,4-dimethoxyphenylethylamine of shock avoidance in rats.
    Gorelick DA; Bridger WH
    Psychopharmacology (Berl); 1977 Apr; 52(2):157-63. PubMed ID: 407599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mescaline, 3,4-dimethoxyphenylethylamine, and adrenaline: sites of electroencephalographic arousal.
    Takeo Y; Himwich HE
    Science; 1965 Dec; 150(3701):1309-10. PubMed ID: 5856999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationship studies on mescaline: the effect of dimethoxyphenylethylamine and N:N-dimethyl mescaline on the conditioned avoidance response in the rat.
    Smythies JR; Sykes EA
    Psychopharmacologia; 1966; 8(5):324-30. PubMed ID: 5923938
    [No Abstract]   [Full Text] [Related]  

  • 6. The effects of dimethoxyphenylethylamine and mescaline on classical conditioning in rats as measured by the potentiated startle response.
    Bridger WH; Mandel IJ
    Life Sci; 1967 Apr; 6(7):775-81. PubMed ID: 6031262
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of mescaline, 3, 4-dimethoxyphenethylamine and 2, 5-dimethoxy-4-methylamphetamine on rat plasma prolactin: evidence for serotonergic mediation.
    Meltzer HY; Fessler RG; Simonovic M; Fang VS
    Life Sci; 1978 Sep; 23(11):1185-92. PubMed ID: 152377
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of a low dosage of mescaline and 3,4-dimethoxyphenylethylamine under two levels of aversive stimulation.
    Levis DJ; Caldwell DF
    Biol Psychiatry; 1971; 3(3):251-7. PubMed ID: 5163810
    [No Abstract]   [Full Text] [Related]  

  • 9. An influence of blood plasma from schizophrenics on an action of 3,4-dimethoxyphenylethylamine.
    Proctor CD; Cho JB; Potts JL; Ashley LG; Douglas JG; Amoroso CP; McGriff JE; Eaton HE
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):95-105. PubMed ID: 5650338
    [No Abstract]   [Full Text] [Related]  

  • 10. Factors affecting an influence of blood plasma from schizophrenics on an action of 3,4-dimethoxyphenylethylamine.
    Proctor CD; Cho JB; Ashley LG; Potts JL; Eaton HE; McGriff JE; Douglas JG; Amoroso CP
    Arch Int Pharmacodyn Ther; 1968 Mar; 172(1):106-21. PubMed ID: 5650321
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of the metabolism of 3,4-dimethoxyphenylethylamine and mescaline in humans.
    Friedhoff AJ; Hollister LE
    Biochem Pharmacol; 1966 Mar; 15(3):269-73. PubMed ID: 5911541
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma factors, amines and their derivatives in schizophrenia.
    Bergen JR
    Res Commun Chem Pathol Pharmacol; 1970 May; 1(3):403-18. PubMed ID: 4944700
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of metabolism of mescaline and 3,4-dimethoxyphenylethylamine in humans.
    Charalampous KD
    Behav Neuropsychiatry; 1971; 2(11):26-9 passim. PubMed ID: 5566331
    [No Abstract]   [Full Text] [Related]  

  • 14. URINARY EXCRETION OF A 3-4, DIMETHOXYPHENYLETHYLAMINE-LIKE SUBSTANCE IN PARKINSON'S DISEASE.
    BARBEAU A; DEGROOT JA; JOLY JG; RAYMOND-TREMBLAY D; DONALDSON J
    Rev Can Biol; 1963; 22():469-72. PubMed ID: 14142201
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of psychotomimetic effect of para-methoxyphenylethylamine and 3,4-dimethoxyphenethylamine in man.
    Brown WT; McGeer PL; Moser I
    Can Psychiatr Assoc J; 1968 Feb; 13(1):91-2. PubMed ID: 5644428
    [No Abstract]   [Full Text] [Related]  

  • 16. Alteration by pretreatment with iproniazid and an inactive mescaline analogue of a behaviour change induced by mescaline.
    Smythies JR; Johnston VS; Bradley RJ
    Nature; 1967 Oct; 216(5111):196-7. PubMed ID: 6057240
    [No Abstract]   [Full Text] [Related]  

  • 17. A comparative study on the metabolism of 3,4-dimethoxyphenylethylamine-C 14 and mescaline-C 14 by rabbit, mouse and rat brain homogenates.
    Shah NS
    Arch Int Pharmacodyn Ther; 1971 Oct; 193(2):357-61. PubMed ID: 5119220
    [No Abstract]   [Full Text] [Related]  

  • 18. Enzymatic 5-hydroxylation of 3,4-dimethoxybeta-phenethylamine.
    Benington F; Morin RD
    Ala J Med Sci; 1974 Oct; 11(4):354-5. PubMed ID: 4460724
    [No Abstract]   [Full Text] [Related]  

  • 19. The pharmacology of hallucinogens.
    Brawley P; Duffield JC
    Pharmacol Rev; 1972 Mar; 24(1):31-66. PubMed ID: 4626282
    [No Abstract]   [Full Text] [Related]  

  • 20. A stereotyped response induced by mescaline in mice as a means of investigating the properties of drugs acting on the CNS.
    MAFFII G; SONCIN E
    J Pharm Pharmacol; 1958 Sep; 10(9):541-52. PubMed ID: 13576429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.